Weighing risks vs. benefits when caring for the aging population is of utmost concern in hospice care. The “Choosing Wisely” guidelines developed in 2012 by the American Geriatrics Society were recently updated to advise against the use of antipsychotics in patients with dementia, to recommend discontinuation cholinesterase inhibitors in patients with dementia that do not show cognitive improvement within 12 weeks, and to emphasis the value of moderate, instead of tight glycemic control in diabetics. These updates are very pertinent to medication management in hospice patients.
Link to original article (04/2015)
